Weiguo Ye - Mar 24, 2025 Form 4 Insider Report for GYRE THERAPEUTICS, INC. (GYRE)

Role
Chief Operating Officer
Signature
/s/ Ruoyu Chen, as attorney-in-fact for Weiguo Ye
Stock symbol
GYRE
Transactions as of
Mar 24, 2025
Transactions value $
$487,500
Form type
4
Date filed
4/25/2025, 04:01 PM
Previous filing
Mar 11, 2025
Next filing
May 14, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GYRE Common Stock Options Exercise $225K +300K $0.75 300K Mar 24, 2025 Direct
transaction GYRE Common Stock Options Exercise $150K +200K +66.67% $0.75 500K Mar 26, 2025 Direct
transaction GYRE Common Stock Options Exercise $113K +150K +30% $0.75 650K Mar 27, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GYRE Stock Option (Right to Buy) Options Exercise $0 -300K -18.02% $0.00 1.37M Mar 24, 2025 Common Stock 300K $0.75 Direct F1
transaction GYRE Stock Option (Right to Buy) Options Exercise $0 -200K -14.65% $0.00 1.17M Mar 26, 2025 Common Stock 200K $0.75 Direct F1
transaction GYRE Stock Option (Right to Buy) Options Exercise $0 -150K -12.87% $0.00 1.02M Mar 27, 2025 Common Stock 150K $0.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options are vested in full.